Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsBiotech/Pharma Issuances on the Rise
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
By Donald Zuhn -- Last week, a post on Patently-O presented some interesting results regarding the percent of utility applications that had issued as patents as compared to the total number of issued patents and abandoned applications for eight technology centers (see "USPTO Grant Rate by Technology Center"). The post indicated that the results had been obtained from an analysis of about 25,000 utility applications filed over the past few years. According to the post, TC 1600 (biotechnology and organic chemistry) had produced the lowest percent of issuances (less than 45%). For a presentation at last month's BIO International Convention...Full post as published by Patent Docs on June 03, 2010 (boomark / email).
Lawsuits and Settlements
Bunk Beds
Injuries on the rise
Medical Records
To Stay out of Pharma's Hands
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Upcoming Patent Events: Pharma/Biotech IP Due Diligence
ACI "Pharma/Biotech IP Due Diligence" Conference, New York, January 30-31
Biotech Patents: Strategies for an Evolving Legal Climate








